The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis

• Egile Nagusiak: Suiyuan Hu (Egilea), Chu Lin (Egilea), Xiaoling Cai (Egilea), Xingyun Zhu (Egilea), Fang Lv (Egilea), Lin Nie (Egilea), Linong Ji (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objective. To assess the association between the use of biological disease-modifying antirheumatic drugs (bDMARDs) and the risk of cardiovascular events in patients with systemic inflammatory conditions. Methods. Eligible cohort studies or randomized controlled trials (RCTs) from inception to Januar...